FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease

(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…

Source link : https://www.medpagetoday.com/spotlight/acr-sjogrens-syndrome/119151

Author :

Publish date : 2025-12-23 13:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

FcRn Blockers Vie to Become First Approved Drug for Sjogren’s Disease

EU Calls for Heart Health Plans Amid Rising Disease Burden

The best space pictures of 2025, from supernovae to moon landings

Related Posts

Cardiology Group to Pay Nearly $5 Million for Alleged Vein Ablation Fraud

U.S. Flu Season Winding Down

Low Testosterone May Raise Risk of ‘Extreme’ Prostate Cancer Progression

New U.S. Lipid Guideline Redefines Risk Categories, Boosts Non-Cholesterol Tests

Reclassification From Type 2 to Type 1 Diabetes Not Uncommon

COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?

Cardiology Group to Pay Nearly $5 Million for Alleged Vein Ablation Fraud

U.S. Flu Season Winding Down

Low Testosterone May Raise Risk of ‘Extreme’ Prostate Cancer Progression

New U.S. Lipid Guideline Redefines Risk Categories, Boosts Non-Cholesterol Tests

Reclassification From Type 2 to Type 1 Diabetes Not Uncommon

COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?

Adapting Communication for Different CLL Patients

Drugs Compared for Steroid-Linked Osteoporosis: What’s Best?

Categories

Archives